Systemic hypertension | 52.4 | 28 | 24 | 23 | Response to PR [16] |
Hyperlipidaemia | 443.5 | 22 | 19 | 13 | |
Coronary artery disease | 30.3 | 34 | 28 | 24 | Mortality [13], response to PR [16] |
Degenerative joint disease | 298.8 | 32 | 27 | 20 | QOL [14] |
BPH | 276.6 | 30 | 26 | 19 | |
DM | 221.6 | | | 11 | QOL [14] |
GORD | 187.7 | 24 | 20 | 16 | AE [41] |
Depression | 176.8 | 28 | 25 | 16 | AE [17] |
Peripheral arterial diseases | 176.7 | | 16 | 10 | |
Congestive heart failure | 165.7 | 37 | 31 | 26 | Mortality [13] |
Substance abuse | 143.9 | 20 | 16 | 12 | |
Atrial fibrillation/flutter | 13 | 25 | 20 | 15 | Mortality [13] |
Anxiety | 121.9 | 23 | 16 | 12 | Mortality (females) [13], AE [17] |
Cerebrovascular accident | 110.7 | 23 | 18 | 11 | |
Erectile dysfunction | 10.4 | 23 | 17 | 15 | |
Pulmonary hypertension | 10.2 | 21 | 17 | 12 | Hospitalisation [42] |
OSA | 10.1 | 23 | 17 | 11 | Mortality [40] |
Osteoporosis | 8.4 | | | 11 | |
Bipolar/schizophrenia | 87.8 | 25 | 19 | 12 | |
Pulmonary fibrosis | 6.1 | 23 | 13 | 11 | Mortality [13] |
Gout | 4.2 | 26 | | | |
DM with neuropathy | 4 | 21 | 17 | 10 | Mortality [13], QOL [14] |
Dementia | 32.6 | 19 | 13 | 8 | |